Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Rituximab, Lenalidomide, and Nivolumab in Treating Participants With Relapsed or Refractory Non-Germinal Center Type Diffuse Large B Cell Lymphoma or Primary Central Nervous System Lymphoma

Vanderbilt-Ingram Cancer Center · 2018
ClinicalTrials.gov · Datasets · License: Public Domain · 2018
Open Source ↗
recurrent central nervous system lymphoma, recurrent diffuse large b-cell lymphoma, refractory central nervous system lymphoma, refractory diffuse large b-cell lymphoma, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 1031733
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.